Home > Quotes > LXRX
LXRX

Lexicon Pharmaceuticals, Inc. Common Stock Quote & Summary Data

$13.81
*  
0.15
1.07%
Get LXRX Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading LXRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LXRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Lexicon Pharmaceuticals, Inc. Common Stock Intraday Chart




News for LXRX

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 14.39 $ 15.79
Low $ 13.69 $ 6.6612

The current last sale of $13.81 is 107.32% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development of breakthrough treatments for human disease. We have advanced multiple drug candidates into clinical development and are presently devoting most of our resources to the development of our two most advanced drug candidates: * We are developing telotristat etiprate, or LX1032, an orally-delivered small molecule drug candidate, as a treatment for carcinoid syndrome. We have reported positive top-line data from both our pivotal TELESTAR Phase 3 clinical trial and its companion TELECAST Phase 3 clinical trial of telotristat etiprate in carcinoid syndrome patients. We are presently preparing an application for regulatory approval to market telotristat etiprate in the United States and, if approved, for the commercial launch of telotristat etiprate in the United States.  ... More ...  

Risk Grade

Where does LXRX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?